|
業務類別
|
Biotechnology |
|
業務概覽
|
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by thecompany are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401. |
| 公司地址
| 101 Cambridgepark Drive, Cambridge, MA, USA, 02140 |
| 電話號碼
| +1 617 945-9626 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.serestherapeutics.com |
| 員工數量
| 233 |
| Mr. Thomas J. DesRosier |
Co-Chief Executive Officer, Executive Vice President, Chief Legal Officer and Secretary |
美元 498.00K |
02/03/2026 |
| Mr. Richard N. Kender, M.B.A. |
Executive Chairman of the Board and Interim Chief Executive Officer |
-- |
02/03/2026 |
| Ms. Marella Thorell |
Co-Chief Executive Officer, Executive Vice President, Principal Accounting Officer and Chief Financial Officer |
-- |
02/03/2026 |
| Ms. Kelly Brady |
Executive Vice President and Chief Operating Officer |
-- |
02/03/2026 |
| Dr. Matthew Henn, PhD |
President and Chief Scientific Officer |
-- |
02/03/2026 |
| Dr. Teresa L. Young, PhD |
Executive Vice President, Chief Commercial Officer and Chief Strategy Officer |
-- |
13/03/2025 |
|
|
| Mr. Kurt C. Graves |
Independent Director |
13/03/2025 |
| Dr. Willard H. Dere, M.D. |
Independent Director |
13/03/2025 |
| Mr. Richard N. Kender, M.B.A. |
Executive Chairman of the Board and Interim Chief Executive Officer |
02/03/2026 |
| Dr. Dennis A. Ausiello, M.D. |
Independent Director |
13/03/2025 |
| Dr. Claire M. Fraser, PhD |
Independent Director |
13/03/2025 |
| Mr. Eric D. Shaff |
Director |
22/07/2025 |
| Mr. Paul R. Biondi |
Independent Director |
13/03/2025 |
| Mr. Stephen A. Berenson |
Director |
02/03/2026 |
| Dr. Hans-Juergen Woerle, M.D. |
Director |
06/02/2025 |
|
|
|
|
